Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Recipharm Pharmaceutical Development AB

Closing information (x1000 DKK)

Closing information 2023/12 2022/12 2021/12
Turnover 80,649 Less Arrow 62,452 More Arrow 72,862
Financial expenses 1,952 Less Arrow 1,081 Less Arrow 220
Earnings before taxes 6,552 Less Arrow -5,385 More Arrow -4,676
EBITDA 9,127 Less Arrow -3,038 More Arrow -1,891
Total assets 44,197 Less Arrow 32,756 More Arrow 46,089
Current assets 33,456 Less Arrow 20,654 More Arrow 34,169
Current liabilities 21,989 Less Arrow 14,787 More Arrow 21,775
Equity capital 22,208 Less Arrow 17,969 More Arrow 24,315
- share capital 34 Less Arrow 33 More Arrow 36
Employees (average) 69 Less Arrow 62 More Arrow 64

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 50.2% More Arrow 54.9% Less Arrow 52.8%
Turnover per employee 1,169 Less Arrow 1,007 More Arrow 1,138
Profit as a percentage of turnover 8.1% Less Arrow -8.6% More Arrow -6.4%
Return on assets (ROA) 19.2% Less Arrow -13.1% More Arrow -9.7%
Current ratio 152.1% Less Arrow 139.7% More Arrow 156.9%
Return on equity (ROE) 29.5% Less Arrow -30.0% More Arrow -19.2%
Change turnover 17,875 Less Arrow -4,509 More Arrow -2,633
Change turnover % 28% Less Arrow -7% More Arrow -3%
Chg. No. of employees 7 Less Arrow -2 More Arrow 3
Chg. No. of employees % 11% Less Arrow -3% More Arrow 5%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.